Commercialization of biotechnology in the Asian region. Report of meeting of Asian Productivity Organization (APO) in Osaka, Japan.
Detailed studies on the commercial development of biotechnology in five countries in the Asian Region (viz. Japan, Korea, Taiwan, Thailand, India) indicate a very significant role played by government in strategic planning and R & D financing. Strong growth is projected in some traditional biotechnology products e.g. amino acids such as monosodium glutamate and L-lysine, animal and human vaccines, and in environmental applications of biotechnology. The cash flow from these products will underpin future development and marketing of diagnostics, anticancer and antiviral drugs, particularly in Japan and Korea.